Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

Market Cap	8.89B -23.0%
Revenue (ttm)	3.11B +14.1%
Net Income	650.37M +19.0%
EPS	0.94 +19.2%
Shares Out	693.22M
PE Ratio	13.70
Forward PE	12.34
Dividend	0.35 (2.68%)
Ex-Dividend Date	May 28, 2026

Volume	12,239,481
Open	13.11
Previous Close	13.04
Day's Range	12.74 - 13.12
52-Week Range	12.74 - 21.07
Beta	0.14
Analysts	Strong Buy
Price Target	23.00 (+79.27%)
Earnings Date	Jul 30, 2026

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1995
• Employees: 2,861
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300181

Financial Performance

In 2025, SHE:300181's revenue was 3.04 billion, an increase of 17.96% compared to the previous year's 2.58 billion. Earnings were 631.93 million, an increase of 24.45%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error